The Choice of Antiplatelet Agent for the Secondary Prevention of Cerebral Stroke
DOI:
https://doi.org/10.22141/2224-0713.6.76.2015.78082Keywords:
antiplatelet agents, antiaggregants, ischemic stroke, secondary preventionAbstract
Acute cerebral stroke is one of the major causes of death and disability in the population of Ukraine and all over the world. Stroke and/or transient ischemic attack are among the most powerful predictors of cardiovascular events, including recurrent cerebral stroke, therefore stroke prevention in these patients — an extremely important task. The article presents current views on the role of antiplatelet agents in the prevention of recurrent strokes and transient ischemic attacks. In addition, assessment of the effectiveness and safety of different antiplatelet agents is presented from the perspective of evidence-based medicine.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 M.A. Trishchynska
This work is licensed under a Creative Commons Attribution 4.0 International License.